FDA Inspection 1003867 — Central Jersey Blood Center, Inc.

Central Jersey Blood Center, Inc. — FEI 3008300945

The FDA completed an inspection of Central Jersey Blood Center, Inc. on Feb 27, 2017 in Eatontown, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Feb 27, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Eatontown, NJ (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.